Page 3 of 8

CM18.1-3 | CM18.1-3 | International Health Agencies and Pandemic Prevention — Summary & Reflection

KEY TAKEAWAYS

International health addresses health problems that cross national boundaries, requiring multilateral cooperation. The core rationale is epidemiological: communicable diseases, environmental hazards, and health security threats are shared problems. The international health architecture comprises four tiers: (1) UN-affiliated multilateral bodies — WHO (primary norm-setter and IHR framework), UNICEF (child/maternal health), UNFPA (reproductive health), UNDP (development-health), World Bank (largest LMIC health financier); (2) bilateral agencies — USAID, FCDO, JICA, GIZ; (3) public-private partnerships — GAVI (vaccines), Global Fund (HIV/TB/malaria), Gates Foundation; (4) WHO's 6 regional offices, with India in SEARO (New Delhi HQ). The IHR 2005 framework — legally binding on 196 states — obligates countries to report potential PHEICs within 24 hours, and empowers the WHO Director-General to declare a PHEIC based on four criteria. India's interface with this architecture runs through IDSP → NCDC → DGHS (national IHR focal point) → WHO SEARO. India is simultaneously a recipient of international assistance and a contributor — as the world's largest generic medicine and vaccine exporter — to global health security.

REFLECT

During the COVID-19 pandemic, India faced a tension between its IHR 2005 obligations to report transparently and the political sensitivity of epidemic data. Consider: what incentives might cause a country to delay PHEIC-triggering notifications to WHO? What reforms — structural, financial, or political — could reduce that delay? Reflect on India's 'Vaccine Maitri' initiative: was the decision to export vaccines before achieving domestic coverage consistent with the principles of international solidarity and equity that underpin the multilateral health architecture? How would you advise a district CMO to integrate international health frameworks into their daily practice?